Abigail C. Wright

institute for clinical and economic review

H指数:14

被引数:585

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Informing the US Medicare drug price negotiation for Trelegy Ellipta and Breo Ellipta: Evaluating the impact of real-world evidence

为美国医疗保险药品价格谈判提供Trelegy Ellipta和Breo Ellipta的定价依据：评估真实世界证据的影响

Value in Health

IF6

2026-03-180

PRE

AI-generated commentaries and letters to the editor of peer-reviewed publications: editors and authors beware!

人工智能生成的评论和信件给同行评审出版物的编辑: 编辑和作者当心!

JOURNAL OF MENTAL HEALTH

IF3.2

2025-12-010

PRE

Effects of legalizing recreational cannabis sales on cannabis use and cannabis-related disorder among presentations to a psychiatric emergency service

合法化娱乐性大麻销售对精神病急诊服务中就诊者的大麻使用及大麻相关障碍的影响

American Journal of Preventive Medicine

IF4.5

2025-10-080

PRE

Secondary stressors and their psychosocial impacts on healthcare staff: lessons from a qualitative systematic review from the COVID-19 pandemic in the UK

次级应激源及其对医疗人员心理社会影响：来自英国COVID-19疫情期间一项定性系统综述的启示

BJPSYCH OPEN

IF3.5

2025-05-190

A network meta-analysis of KarXT and commonly used pharmacological interventions for schizophrenia

KarXT和精神分裂症常用药物干预的网络荟萃分析

SCHIZOPHRENIA RESEARCH

IF3.5

2024-12-016

PRE

Informing the United States Medicare Drug Price Negotiation for Apixaban and Rivaroxaban: Methodological Considerations for Value Assessments Many Years After Launch

告知阿哌沙班和利伐沙班的美国医疗保险药品价格谈判: 上市多年后价值评估的方法学考虑

VALUE IN HEALTH

IF6

2024-11-010

PRE

A framework for evaluating the diversity of clinical trials

JOURNAL OF CLINICAL EPIDEMIOLOGY

IF5.2

2024-05-013

PRE

Experiencing hallucinations in daily life: The role of metacognition

SCHIZOPHRENIA RESEARCH

IF3.5

2024-03-012

OAAI

Correction: On the proportion of patients who experience a prodrome prior to psychosis onset: a systematic review and meta-analysis ( Feb , 10.1038/s41380-024-02415-w, 2024)

更正: 关于精神病发作前经历前驱症状的患者比例: 系统回顾和荟萃分析 (2月，10.1038/s41380-024-02415-w，2024)

MOLECULAR PSYCHIATRY

IF10.1

2024-02-140

On the proportion of patients who experience a prodrome prior to psychosis onset: A systematic review and meta-analysis

关于精神病发作前经历前驱症状的患者比例: 系统回顾和荟萃分析

MOLECULAR PSYCHIATRY

IF10.1

2024-02-023

Metacognition and psychosis-spectrum experiences: A study of objective and subjective measures

SCHIZOPHRENIA RESEARCH

IF3.5

2023-12-012

OAAI

Evaluation of Diversity of Clinical Trials Informing Health Technology Assessments in the United States: A 5-Year Analysis of Institute for Clinical and Economic Review Assessments

VALUE IN HEALTH

IF6

2023-09-014

OAAI

'Feeling' or 'sensing' the future? Testing for anomalous cognitions in clinical versus healthy populations

HELIYON

IF3.6

2022-11-011

OAAI

A Randomized Controlled Trial of the Effects of Early Intervention Services On Insight in First Episode Psychosis

SCHIZOPHRENIA BULLETIN

IF4.8

2022-08-233

Relationships among subclinical psychotic symptoms in young adults over time

PSYCHIATRY RESEARCH

IF3.9

2022-08-011

PRE

Relationship between patterns of cannabis use and functional and symptomatic trajectories in first-episode psychosis

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

IF3.7

2022-07-289

PRE

Photo-elicitation for teaching awareness of ageism in healthcare

MEDICAL EDUCATION

IF5.2

2022-03-073

PRE

Psychotic behaviors during COVID-19: Should conspiracist ideation be included within the continuum model of psychosis?

SCHIZOPHRENIA RESEARCH

IF3.5

2021-11-014

PRE

Does comprehensive cognitive remediation improve emotion perception?

COGNITIVE NEUROPSYCHIATRY

IF0.9

2021-06-271

PREAI

The relationship between conventional clinical assessments and momentary assessments of symptoms and functioning in schizophrenia spectrum disorders: A systematic review

SCHIZOPHRENIA RESEARCH

IF3.5

2021-06-0112

PRE

Abigail C. Wright

个人简介

教育背景

工作经历

荣誉奖项

研究方向